Moderna’s mRNA Flu Vaccine Wins FDA Advisory Committee Backing
2026-06-18 18:55:13
Moderna Inc.’s influenza vaccine made with mRNA technology was recommended for approval by outside advisers to the US Food and Drug Administration. According to Bloomberg, the backing is a positive development for a product that has been contentious at the agency.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
